{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:58:28Z","timestamp":1773021508436,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.contraception.2010.05.013","type":"journal-article","created":{"date-parts":[[2010,6,29]],"date-time":"2010-06-29T08:24:07Z","timestamp":1277799847000},"page":"513-519","source":"Crossref","is-referenced-by-count":21,"title":["Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days' LMP: a randomized controlled trial"],"prefix":"10.1016","volume":"82","author":[{"given":"Sheila","family":"Raghavan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodica","family":"Comendant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Digol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergiu","family":"Ungureanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iurie","family":"Dondiuc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steliana","family":"Turcanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2010.05.013_bib1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1471-0528.2006.00948.x","article-title":"Regimens of misoprostol with mifepristone for early medical abortion: A randomized trial","volume":"113","author":"Shannon","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2010.05.013_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.contraception.2004.06.012","article-title":"Expanding medical abortion in Tunisia: Women's experiences from a multi-site expansion study","volume":"70","author":"Hajri","year":"2004","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2010.05.013_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/13625180500361058","article-title":"Mifepristone medical abortion in Albania: results from a pilot clinical research study","volume":"11","author":"Bracken","year":"2006","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"10.1016\/j.contraception.2010.05.013_bib4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/13625180500284581","article-title":"Home use of two doses of misoprostol after mifepristone for medial abortion: a pilot study in Sweden and France","volume":"10","author":"Clark","year":"2005","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.05.013_bib5","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0140-6736(00)04563-3","article-title":"Can women in less-developed countries use a simplified medical abortion regimen?","volume":"357","author":"Elul","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.05.013_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.contraception.2003.08.019","article-title":"The medical abortion experiences of married and unmarried women in Tunis, Tunisia","volume":"69","author":"Blum","year":"2004","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2010.05.013_bib7","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/AOG.0b013e31818d8eb4","article-title":"Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial","volume":"112","author":"Winikoff","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.05.013_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.contraception.2008.09.001","article-title":"Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol","volume":"79","author":"Raghavan","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.05.013_bib9","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM199504133321502","article-title":"Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol","volume":"332","author":"el-Refaey","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.05.013_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(01)00229-3","article-title":"Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion","volume":"64","author":"Schaff","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.05.013_bib11","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States","volume":"338","author":"Spitz","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.contraception.2010.05.013_bib12","first-page":"871","article-title":"ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 67, October 2005","volume":"106","author":"ACOG","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.05.013_bib13","author":"National Abortion Federation (US, CA)"},{"key":"10.1016\/j.contraception.2010.05.013_bib14","series-title":"Evidence-based Clinical Guidelines No. 7.","article-title":"The care of women requesting induced abortion","author":"Royal College of Obstetricians and Gynaecologists","year":"2004"},{"key":"10.1016\/j.contraception.2010.05.013_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa0809146","article-title":"Rates of serious infection after changes in regimens for medical abortion","volume":"361","author":"Fjerstad","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.contraception.2010.05.013_bib16","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/humrep\/17.7.1738","article-title":"Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.05.013_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0029-7844(97)00419-5","article-title":"Vaginal misoprostol compared with oral misoprostol in termination of second trimester pregnancy","volume":"90","author":"Ho","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.05.013_bib18","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-0528.2005.00638.x","article-title":"A randomized controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation","volume":"112","author":"Hamoda","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2010.05.013_bib19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2005.05.017","article-title":"Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period","volume":"72","author":"Middleton","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.05.013_bib20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1479-828X.2005.00484.x","article-title":"First trimester abortion with mifepristone and three doses of sublingual misoprostol: a pilot study","volume":"45","author":"Singh","year":"2005","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2010.05.013_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.contraception.2007.03.010","article-title":"Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center","volume":"76","author":"Mundle","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2010.05.013_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13625180902916020","article-title":"Increasing women's choices in medical abortion: A study of misoprostol 400 mcg swallowed immediately or held sublingually following 200 mg mifepristone","volume":"14","author":"Akin","year":"2009","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.05.013_bib23","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/humrep\/deg475","article-title":"A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation","volume":"18","author":"Tang","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.05.013_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.contraception.2003.07.004","article-title":"A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation","volume":"68","author":"Hamoda","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.05.013_bib25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/17.2.332","article-title":"Pharmacokinetics of different routes of administration of misoprostol","volume":"10","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.05.013_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.contraception.2004.06.014","article-title":"Comparison of misoprostol plasma concentrations following buccal and sublingual administration","volume":"71","author":"Schaff","year":"2005","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410003306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410003306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T04:28:15Z","timestamp":1544416095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782410003306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0010782410003306"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2010.05.013","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}